Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Advances in bladder cancer management / / editors, Shahrokh F. Shariat, Evanguelos Xylinas
| Advances in bladder cancer management / / editors, Shahrokh F. Shariat, Evanguelos Xylinas |
| Pubbl/distr/stampa | London, [England] : , : Future Medicine, , 2015 |
| Descrizione fisica | 1 online resource (223 pages) |
| Disciplina | 616.99462 |
| Soggetto topico | Bladder - Cancer |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-78084-424-7
1-78084-423-9 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910467813103321 |
| London, [England] : , : Future Medicine, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Advances in bladder cancer management / / editors, Shahrokh F. Shariat, Evanguelos Xylinas
| Advances in bladder cancer management / / editors, Shahrokh F. Shariat, Evanguelos Xylinas |
| Pubbl/distr/stampa | London, [England] : , : Future Medicine, , 2015 |
| Descrizione fisica | 1 online resource (223 pages) |
| Disciplina | 616.99462 |
| Soggetto topico | Bladder - Cancer |
| ISBN |
1-78084-424-7
1-78084-423-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910794870903321 |
| London, [England] : , : Future Medicine, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Advances in bladder cancer management / / editors, Shahrokh F. Shariat, Evanguelos Xylinas
| Advances in bladder cancer management / / editors, Shahrokh F. Shariat, Evanguelos Xylinas |
| Pubbl/distr/stampa | London, [England] : , : Future Medicine, , 2015 |
| Descrizione fisica | 1 online resource (223 pages) |
| Disciplina | 616.99462 |
| Soggetto topico | Bladder - Cancer |
| ISBN |
1-78084-424-7
1-78084-423-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910812995103321 |
| London, [England] : , : Future Medicine, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Advances in the scientific evaluation of bladder cancer and molecular basis for diagnosis and treatment / / edited by Raj Persad and Weranja Ranasinghe
| Advances in the scientific evaluation of bladder cancer and molecular basis for diagnosis and treatment / / edited by Raj Persad and Weranja Ranasinghe |
| Pubbl/distr/stampa | Rijeka, Croatia : , : IntechOpen, , [2013] |
| Descrizione fisica | 1 online resource (140 pages) : illustrations |
| Disciplina | 616.99462 |
| Soggetto topico | Bladder - Cancer |
| ISBN | 953-51-7153-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910317739603321 |
| Rijeka, Croatia : , : IntechOpen, , [2013] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Bladder cancer / / edited by Ja Hyeon Ku, Seoul National University Hospital, Seoul, Korea
| Bladder cancer / / edited by Ja Hyeon Ku, Seoul National University Hospital, Seoul, Korea |
| Autore | Ku Ja Hyeon |
| Pubbl/distr/stampa | London : , : Academic Press, an imprint of Elsevier, , [2018] |
| Descrizione fisica | 1 online resource (xxvii, 700 pages) : illustrations (some color) |
| Disciplina | 616.99462 |
| Collana | Gale eBooks |
| Soggetto topico | Bladder - Cancer |
| ISBN |
0-12-809940-2
0-12-809939-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Section 1. Epidemiology, etiology, and pathophysiology -- Section 2. Diagnosis -- Section 3. Pathology and staging -- Section 4. Treatment for nonmuscle invasive bladder cancer (NMIBC) -- Section 5. Treatment for muscle-invasive bladder cancer (MIBC) -- Section 6. Chemotherapy for metastatic bladder cancer / Bhumsuk Keam -- Section 7. Follow-up (surveillance) -- Section 8. Future perspective in bladder cancer. |
| Record Nr. | UNINA-9910583368703321 |
Ku Ja Hyeon
|
||
| London : , : Academic Press, an imprint of Elsevier, , [2018] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Bladder cancer [[electronic resource] /] / Derek Raghavan, Michael Bailey
| Bladder cancer [[electronic resource] /] / Derek Raghavan, Michael Bailey |
| Autore | Raghaven David |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | Oxford, : Health Press, 2006 |
| Descrizione fisica | 1 online resource (90 p.) |
| Disciplina | 616.99462 |
| Altri autori (Persone) | BaileyMichael |
| Collana | Fast facts |
| Soggetto topico |
Bladder - Cancer
Patient education |
| ISBN |
1-280-81429-2
9786610814299 1-905832-16-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Fast Facts: Bladder Cancer, second edition; Introduction; Chapter 1: Epidemiology and etiology; Chapter 2: Pathology; Chapter 3: Clinical presentation; Chapter 4: Investigations; Chapter 5: Microscopic hematuria; Chapter 6: Management of superficial disease; Chapter 7: Management of muscle-invasive disease; Chapter 8: Management of advanced andmetastatic disease; Chapter 9: Future trends; Useful resources; Index |
| Record Nr. | UNISA-996339115003316 |
|
Raghaven David
|
||
| Oxford, : Health Press, 2006 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Bladder Cancer : A Practical Guide / / edited by Ashish M. Kamat, Peter C. Black
| Bladder Cancer : A Practical Guide / / edited by Ashish M. Kamat, Peter C. Black |
| Edizione | [1st ed. 2021.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2021 |
| Descrizione fisica | 1 online resource (466 pages) |
| Disciplina | 616.99462 |
| Soggetto topico |
Urology
Cancer - Treatment Radiology Cancer Therapy Càncer de bufeta |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-030-70646-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Section 1: Patient Evaluation -- Screening -- Evaluation for Signs and Symptoms -- Cystoscopy Inc -- Using Urine Markers -- Risk Stratification -- Assessment/Management of Frailty -- Section 2: TURBT (Tumor Resection) -- Indications -- Patient Preparation -- Surgical Technique -- Peri-operative Care -- Management of Common Complications -- Pathologist Assessment and Report -- Oncologic Monitoring -- Section 3: Adjvuant Intravesical Therapy -- Introduction: Choice of Therapy -- BCG -- Chemo -- Device Assisted -- Intravesical Salvage Therapy -- Section 4: Radical Cystectomy -- Indications -- Patient Preparation -- Surgical Technique -- Peri-operative Care -- Management of Common Complications -- Pathologist Assessment and Report -- Oncologic Monitoring -- Section 5: Urinary Diversion -- Incontinent -- Continent Cutaneous -- Orthotopic Neobladder -- Section 6: Peri-operative Chemotherapy -- Neoadjuvant -- Adjuvant -- Section 7: Trimodal Therapy (Radiation) -- Indications -- Patient Preparation -- Concomitant Chemo -- External Beam Radiation -- Management of Recurrence -- Section 8: Systemic Therapy for Advanced Bladder Cancer -- Chemotherapy -- Immunotherapy -- Novel Therapies -- Section 9: Managing Variant Histology -- Squamous/Glandular Differentiation -- Micropapillary -- Sarcomatoid -- Small Cell/Neuroendocrine -- Other -- Squamous -- Adenocarcinoma -- Section 10: Clinical Trials in Bladder Cancer: Practical Pearls -- Bladder Cancer Disease States -- NMIBC -- Metastatic. |
| Record Nr. | UNINA-9910495153903321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Bladder cancer : from basic science to robotic surgery / / edited by Abdullah Erdem Canda
| Bladder cancer : from basic science to robotic surgery / / edited by Abdullah Erdem Canda |
| Pubbl/distr/stampa | Rijeka, Croatia : , : InTech, , [2012] |
| Descrizione fisica | 1 online resource (472 pages) : illustrations |
| Disciplina | 616.99462 |
| Soggetto topico | Bladder - Cancer |
| ISBN | 953-51-6712-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Bladder cancer |
| Record Nr. | UNINA-9910138261703321 |
| Rijeka, Croatia : , : InTech, , [2012] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Comprehensive diagnostic approach to bladder cancer : molecular imaging and biomarkers / / Marc A. Bjurlin, Richard S. Matulewicz, editors
| Comprehensive diagnostic approach to bladder cancer : molecular imaging and biomarkers / / Marc A. Bjurlin, Richard S. Matulewicz, editors |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2021] |
| Descrizione fisica | 1 online resource (232 pages) |
| Disciplina | 616.99462 |
| Soggetto topico |
Bladder - Cancer - Diagnosis
Urinary Bladder Neoplasms - diagnosis Urinary Bladder Neoplasms - diagnostic imaging Càncer de bufeta Diagnòstic per la imatge |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-030-82048-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Foreword -- Contents -- Contributors -- Chapter 1: Epidemiology of Bladder Cancer: Trends and Disparities -- Incidence and Natural History -- Non-muscle Invasive Bladder Cancer -- Muscle-Invasive Bladder Cancer -- Metastatic Bladder Cancer -- Variant Histology -- National and Global Trends -- Disparities in the Diagnosis and Treatment of Bladder Cancer -- Gender -- Race -- Insurance -- Geography -- Financial Toxicity -- Disparities in Survivorship -- Urinary Diversion -- Sexual Function -- Conclusion -- References -- Chapter 2: Environmental and Genetic Factors Contributing to Bladder Carcinogenesis -- Introduction -- Environmental Risk Factors -- Arsenic -- Aristolochia -- Diet -- Food -- Fluid Intake -- Vitamins -- Medications -- Cyclophosphamide -- Pioglitazone -- Phenacetin -- Radiation -- Immunosuppression -- Infection -- Recurrent Bacterial Urinary Tract Infections -- Schistosoma haematobium -- Epstein-Barr Virus -- Neisseria gonorrhea -- Human papillomavirus -- Polyomaviruses -- Smoking -- Cigarette Smoking -- Electronic Cigarettes -- Others -- Gender -- Race -- Occupational Risk -- Polyaromatic Hydrocarbons -- Hair Dye -- Genetic Predisposition -- Genetic Polymorphisms -- Germline Mutations -- Conclusion -- References -- Chapter 3: Strategies for Bladder Cancer Screening -- Introduction -- Rationale for Screening -- High-Risk Populations -- Age -- Cigarette Smoking -- Prior Screening Trials: Comparing Cohorts and Methods of Screening -- Urine Dipstick (Chemical Reagent Strip for Hemoglobin) -- Urine Cytology -- Other Urinary Biomarkers -- Looking Forward: Design of and Challenges in an Ongoing Bladder Cancer Screening Trial -- References -- Chapter 4: Staging of Bladder Cancer -- Introduction -- Diagnosis -- Staging Modalities -- TURBT -- Cystoscopy Enhancements -- Resection Method -- Influence of Energy Type.
Special Staging Circumstances: Diverticulae -- Bimanual Exam -- Accuracy of Staging: Importance of Repeat TURBT -- Imaging -- Staging -- Current TNM Staging -- Historical Considerations and Updates -- Risk Stratification Schema -- Surveillance Protocols -- Non-muscle-Invasive Disease -- Recurrence After BCG -- Conclusion -- References -- Chapter 5: Conventional and Investigational Imaging Modalities -- Introduction -- Role of Imaging in the Diagnosis of Bladder Cancer and Directing the Therapeutic Approach -- Imaging Modalities -- Ultrasound -- Imaging Technique -- Imaging Role, Clinical Impact, and Accuracy of US -- Computed Tomography -- Imaging Technique -- Imaging Role, Clinical Impact, and Accuracy of CT -- Magnetic Resonance Imaging -- Imaging Technique -- MR Urography -- Bladder Cancer Staging -- Imaging Role, Clinical Impact, and Accuracy of MR -- MR Urography -- Bladder Cancer Staging -- T Staging -- N Staging -- Radiomics and Bladder Cancer -- Conclusion and Future Directions -- References -- Chapter 6: Evaluation of Hematuria -- Epidemiology and Definitions of Hematuria -- Etiologies of Hematuria -- Pseudohematuria -- Benign Causes of Hematuria -- Malignant Causes of Hematuria -- Indications for Workup of Hematuria -- AUA Guideline Review -- Variation Among International Hematuria Guidelines -- Patient History and Unique Patient Circumstances -- Women -- Antithrombotics -- Components of the Diagnostic Evaluation of Hematuria -- Cystoscopy -- Upper Tract Imaging -- Cross-Sectional Imaging with Contrast Enhancement -- Renal Ultrasound -- Urine Cytology -- Future Potential Use of Urine Markers and Biomarkers -- Risks Associated with Evaluation -- Novel Risk Stratification Approaches for Microscopic Hematuria -- Conclusion -- References -- Chapter 7: Molecular Imaging Modalities: Applications of Current and Novel Radiotracers -- Introduction. Assessment of Residual Tumor After TURBT -- Bladder Cancer Staging -- 18F-FDG PET/CT -- Primary Tumor Staging -- Lymph Node Staging -- 18F-FDG PET/MRI -- 11C-Choline PET/CT -- 11C-Acetate PET -- Response to Neoadjuvant Chemotherapy -- Detection of Bone Metastases -- Radiotracers and Immunotherapy -- Investigational Radiotracers -- Imaging Guidelines -- Non-muscle-Invasive Bladder Cancer -- Muscle-Invasive and Metastatic Bladder Cancer -- Conclusions -- References -- Chapter 8: Optical Techniques for Bladder Cancer Detection: The Role of Cystoscopy and Enhanced Cystoscopy -- Standard White Light Cystoscopy -- Techniques to Reduce Pain -- Use of Antibiotics -- Enhanced Cystoscopic Modalities -- Narrow-Band Imaging -- Blue Light Cystoscopy with TURBT -- Flexible Blue Light Cystoscopy -- Near-Infrared Fluorescence Imaging -- AUA/SUO Guidelines -- Future Directions -- Conclusion -- References -- Chapter 9: Urine Cytology in the Clinical Management of Bladder Cancer -- Introduction -- Urinary Tract Cytomorphology and the Paris System for Reporting Urinary Cytology (TPS) -- Urine Cytology in Clinical Practice -- Methods of Obtaining Urine Cytology -- Specimen Preparation and Adequacy Assessment -- Performance Characteristics of Urine Cytology in Detecting Clinically Significant UC of the Bladder -- Urine Cytology in the Diagnostic Evaluation of Hematuria -- Urine Cytology for Surveillance of UC of the Bladder -- Conclusion -- References -- Chapter 10: Urinary Biomarkers: Current Status and Future Opportunities -- Introduction -- Defining an Ideal Bladder Cancer Diagnosis and Surveillance Test -- Current Commercially Available Tests for Bladder Cancer Diagnosis -- UroVysion -- Bladder Tumor Antigen (BTA) -- Cx Bladder -- NMP22 BladderChek -- Xpert Detection -- UroSEEK -- AssureMDx -- Current Commercial Tests for Bladder Cancer Surveillance -- UroVysion. ImmunoCyt/uCyt+ -- BTA Stat/BTA Trak -- NMP22 BladderChek/NMP22-BC -- Cx Bladder Monitor -- Uromonitor -- Epicheck -- Potential Urinary Biomarkers -- Protein Biomarkers -- Genomic Biomarkers -- Telomerase -- Fibroblast Growth Factor Receptor 3 -- Aurora Kinase A -- Epigenetic Biomarkers -- DNA Methylation -- MicroRNAs -- Transcriptomic Biomarkers -- Inflammatory Biomarkers -- Metabolic Biomarkers -- Combination Biomarkers -- Conclusions -- References -- Chapter 11: Bladder Cancer Genomics: Indications for Sequencing and Diagnostic Implications -- Introduction -- Primer on Next-Generation Sequencing -- Muscle-Invasive Bladder Cancer -- Non-muscle-Invasive Bladder Cancer -- Advanced and Metastatic Bladder Cancer -- Germline Alterations -- Liquid Biopsy -- Circulating Tumor Cells and Cell-Free Tumor DNA -- Urinary Cell-Free Tumor DNA -- Guidelines and Practical Approach -- Conclusions -- References -- Chapter 12: Novel and Investigational Diagnostics: Liquid Biopsy and Beyond -- Introduction -- Circulating Tumor Cells -- Circulating Tumor DNA -- Circulating Tumor RNA -- Metabolites -- Other Serum-Based Biomarkers -- Conclusion -- References -- Index. |
| Record Nr. | UNINA-9910502993403321 |
| Cham, Switzerland : , : Springer, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Management of muscle invasive bladder cancer / / Sanchia S. Goonewardene [and five others]
| Management of muscle invasive bladder cancer / / Sanchia S. Goonewardene [and five others] |
| Autore | Goonewardene Sanchia |
| Edizione | [1st ed. 2021.] |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2021] |
| Descrizione fisica | 1 online resource (XXXIX, 590 p. 37 illus. in color.) |
| Disciplina | 616.99462 |
| Collana | Management of urology |
| Soggetto topico | Bladder - Cancer |
| ISBN | 3-030-57915-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 1. Introduction to muscle invasive bladder cancer -- 2. Epidemiology and risk factors in muscle invasive bladder cancer -- 3. The molecular basis of muscle invasive bladder cancer -- 4. Histological variants in MIBC - squamous cell and squamous differentiation -- 5. Histological variants in muscle invasive bladder cancer – adenocarcinoma -- 6. Histological variants in muscle invasive bladder Cancer - sarcomatoid cancer -- 7. MIBC Carcinosarcoma -- 8. Muscle invasive bladder cancer- small cell -- 9. MIBC plasmacytoid -- 10. MIBC and micropapillary bladder cancer -- 11. MIBC bladder cancer assessment and diagnosis -- 12. A systematic review on blue light cystoscopy in bladder cancer diagnostics -- 13. A systematic review on the staging conundrum in bladder cancer -- 14. Current state of investigations and limitations in muscle invasive bladder cancer -- 15. Risk stratification in bladder cancer -- 16. Preventative measures for those with high risk MIBC -- 17. Bladder cancer risk post pelvic irradiation -- 18. A systematic review on bladder preservation strategies and MIBC -- 19. Partial cystectomy -- 20. Muscle invasive bladder cancer and neoadjuvant chemotherapy -- 21. Controversies in clinical effectiveness of neoadjuvant chemotherapy -- 22. Trimodal therapy in bladder cancer -- 23. Systematic review on trimodal therapy in bladder cancer -- 24. Trimodal therapy - a systematic review -- 25. Reviews related to trimodal therapy for MIBC -- 26. Radical cystectomy lap open robotic -- 27. Prostate sparing cystectomy - a systematic review -- 28. A systematic review on nerve sparing cystoprostatectomy -- 29. MIBC - orthotopic vs ileal conduit -- 30. MIBC - a systematic review on orthotopic neobladder vs. ileal conduit -- 31. MIBC and radical cystectomy in the elderly -- 32. MIBC radical radiotherapy -- 33. MIBC - quality of life with urinary diversion -- 34. Neoadjuvant chemotherapy for muscle invasive bladder cancer -- 35. Muscle invasive bladder cancer and the staging conundrum -- 36. Radical cystectomy outcomes -- 37. Muscle Invasive bladder cancer and neoadjuvant chemotherapy -- 38. Muscle invasive bladder cancer and the staging conundrum -- 39. Physical pre-habilitation prior to radical cystectomy -- 40. Exercise therapy pre surgery -- 41. Patient fitness for surgery -- 42. CPEX testing prior to major urological surgery -- 43. Cardio-pulmonary exercise testing and major urological surgery -- 44. Robotic radical cystectomy and enhanced recovery -- 45. The robotic approach to redo surgery -- 46. Robotic cystectomy and intracorporeal neobladder formation -- 47. Secondary pelvic malignancies and bladder cancer -- 48. Organ sparing cystectomy -- 49. Robotic radical cystectomy -- 50. Robotic cystectomy and intracorporeal stoma formation -- 51. Orthotopic neobladders vs. ileal conduits -- 52. The role of enhanced recovery in robotic cystectomy -- 53. Robotic radical cystectomy and lymph node dissection -- 54. Robotic cystectomy and sentinel node mapping -- 55. Robotic radical cystectomy and intracorporeal stoma formation -- 56. Lap vs open vs robotic cystectomy -- 57. A systematic review on obesity in bladder cancer -- 58. Systematic review results on obesity in bladder cancer -- 59. Reviews on BMI and bladder cancer -- 60. Survivorship Issues in muscle invasive bladder cancer -- 61. Muscle invasive bladder cancer and health related quality of life -- 62. Body image in bladder cancer -- 63. The rationale for neoadjuvant chemotherapy -- 64. Support for partners in bladder cancer. |
| Record Nr. | UNINA-9910483567203321 |
|
Goonewardene Sanchia
|
||
| Cham, Switzerland : , : Springer, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
